Jim Post, CEO
Jim Post, an Executive Advisor to Water Street Healthcare Partners, was appointed CEO of ALCOR in February 2022 and serves on the Board of Directors. Jim has a strong record of leading teams and businesses to drive innovation in healthcare. As president of the anatomic pathology business for Thermo Fisher Scientific, Jim spearheaded its turnaround, growth and successful sale to global healthcare company PHC Holdings Corporation (PHC). He led the integration of the business into PHC as president and CEO of the newly formed entity, Epredia, where he helped position it as a global leader in precision cancer and tissue diagnostics. Prior to Thermo Fisher, Jim held key management positions with Alere, the world leader in point-of-care and rapid diagnostic devices, including president of its global hospital business. Jim began his career in the healthcare instrument business with United States Surgical, where he was promoted to positions of increasing responsibility. He is a graduate of the University of Rochester.
Karla Ruggeri, General Manager
Mrs. Karla Ruggeri Natale received a Bachelor of Arts in Modern Languages from Providence College in 2008, with a concentration on Italian Studies. While receiving her degree, she spent a semester studying at the American Institute of Foreign Study in Rome in 2007.
After graduation, Karla joined OST Medical as an International Sales and Marketing Representative, and within three years had quadrupled the company’s international sales.
After the merger of OST Medical and Diagnostic Systems Corp. in 2011, Karla’s management responsibilities increased greatly with regards to the overall operations of ALCOR Scientific. She has spear-headed every marketing campaign, including advertisements and trade shows, for both the Enteral and Diagnostic product lines domestically and internationally.
In addition to her extensive Sales and Marketing activities, she also oversees every aspect of ALCOR’s Commercial Operations including Customer Service, Technical Support, Manufacturing, and Quality Assurance.
Peter Sacchetti, CTO
Mr. Peter Sacchetti was formerly a senior executive in Elan Pharma where he oversaw the enteral and diagnostic products development. In 1999, he developed the first enteral devices which were to become the foundation of ALCOR enteral product line.
Mr. Sacchetti has over 30 years experience in management, engineering, and quality assurance in the medical, automotive and aerospace industry and has a number of patents applicable to these fields.
Carlo Ruggeri, Founder
Mr. Carlo Ruggeri is a private healthcare investor with significant experience in developing and operating emerging companies, having served in senior management positions with various U.S. and European healthcare companies.
Mr. Ruggeri is a Sponsor of Trevi Health Ventures LP and in his recent past he has been on the board of Sicor, Sequitor Medical Technologies and CVP.
Previously, he served as CEO of Vega Biomedical, a company which he developed and expanded and which was later acquired by Elan Corporation in 1990.
From 1990 until 1997 he served as the President at Elan Pharma Inc, where he had world-wide responsibilities for Elan’s diagnostic and enteral nutrition business.